pharmaphorum May 21, 2024
Phil Taylor

The FDA is asking digital health technology developers to come up with a solution to measuring a common symptom of Parkinson’s disease that can have a serious impact on patients.

People with Parkinson’s sometimes experience temporary, involuntary periods where they are unable to move their feet when trying to walk – known as freezing of gait (FoG) – which can have a detrimental effect on balance and increase their risk of falling.

According to the Parkinson’s Foundation, freezing generally only lasts a few seconds, but it is one of the more frustrating and dangerous symptoms of the disease, with patients feeling like their feet are glued to the ground.

The exact cause of freezing is unknown, but it sometimes happens...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Patient / Consumer, Provider, Technology
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article